Core Viewpoint - A shareholder has filed a securities class action lawsuit against Bath & Body Works, Inc. for alleged misrepresentations regarding the Company's financial guidance during the period from June 4, 2024, to November 19, 2025 [1][2]. Group 1 - The lawsuit represents a class of investors who purchased or acquired Bath & Body Works securities within the specified timeframe [1]. - Defendants are accused of making misrepresentations concerning the Company's financial guidance [2]. - Interested parties can file to serve as lead plaintiff by March 13, 2026, with no fees or expenses required from shareholders [3]. Group 2 - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has represented both individual investors and large pension funds [4].

Core Points - A shareholder has filed a securities class action lawsuit on behalf of investors who purchased or acquired CoreWeave, Inc. securities between March 28, 2025, and December 15, 2025 [1] - The lawsuit alleges that the defendants made misrepresentations regarding the Company's ability to meet customer demand for its services [2] - Interested parties can file to serve as lead plaintiff by March 13, 2026, with no fees or expenses for shareholders [3] Company Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large public and private pension funds [4]

Core Viewpoint - The lawsuit against Primo Brands Corporation alleges that the company misrepresented the success of its merger with BlueTriton Brands, leading to significant operational failures and substantial investor losses [2][4][6]. Group 1: Lawsuit Details - The lawsuit aims to recover losses incurred by investors following the revelation of a severe operational crisis post-merger, contradicting management's claims of a "flawless" integration [2][4]. - The complaint highlights that the integration process led to severe technology breakdowns, supply disruptions, and customer service issues, which were not disclosed to investors [6]. Group 2: Disclosure Events - The first major disclosure occurred on August 7, 2025, when the company reported weak Q2 results and reduced guidance, attributing some issues to "service problems," resulting in a 9% stock drop [6]. - The final disclosure on November 6, 2025, involved a significant reduction in full-year adjusted EBITDA guidance and the replacement of the CEO, causing the stock to plummet by 21% [3][6]. Group 3: Management's Response - The new CEO described the operational issues as "self-inflicted," confirming the severity of the undisclosed problems that had plagued the company [3][4]. - The investigation is focused on when management became aware of the failures in technology and operational integration [4]. Group 4: Investor Actions - Investors who purchased PRMB shares during the Class Period (June 17, 2024 – November 6, 2025) and suffered losses are encouraged to contact Hagens Berman for potential lead plaintiff status in the lawsuit [5][6].

Core Viewpoint - Hagens Berman is notifying investors about a securities class action against StubHub Holdings, Inc. regarding undisclosed trends in its IPO documents that allegedly led to a significant decline in free cash flow [1][5]. Group 1: Legal Proceedings - The lead plaintiff deadline for the class action is set for January 23, 2026 [4]. - The lawsuit claims that StubHub failed to disclose adverse vendor payment trends that negatively impacted liquidity [4][8]. - Investors who purchased StubHub securities during the September 2025 IPO and incurred losses are encouraged to contact the firm [3]. Group 2: Financial Impact - StubHub reported a free cash flow decline of 143%, resulting in a negative cash flow of $4.6 million for the quarter ending November 13, 2025 [6]. - The company's stock price fell over 20% in one day following the announcement of its financial results and has traded as much as 56% below its IPO price of $23.50 [6]. Group 3: Company Disclosures - The lawsuit challenges the transparency of StubHub's IPO Registration Statement, alleging that it misrepresented the company's financial health while omitting critical information about vendor payment timing changes [5][8]. - Hagens Berman is investigating whether the IPO documents should have disclosed the vendor payment issues that significantly affected free cash flow [7].

Core Viewpoint - Telix Pharmaceuticals Limited is under investigation for potential claims related to a federal securities class action, with a deadline for investors to seek lead plaintiff status set for January 9, 2026 [1] Group 1 - Faruqi & Faruqi, LLP, a prominent national securities law firm, is leading the investigation into Telix Pharmaceuticals [1] - The investigation pertains to potential claims against Telix Pharmaceuticals Limited, which trades on NASDAQ under the ticker TLX [1]

Core Viewpoint - Fermi Inc. is facing a federal securities class action lawsuit due to allegations of misleading statements regarding its Project Matador campus and tenant commitments, which has led to significant investor losses following the termination of a key funding agreement [4][6][9]. Group 1: Company Overview - Fermi Inc. (NASDAQ: FRMI) completed its IPO on October 1, 2025, offering approximately 32.5 million shares at $21.00 per share, with plans to develop a large electric generation campus for AI data centers [7]. - The registration statement highlighted a "First Tenant" for the Project Matador site, with a letter of intent signed on September 19, 2025, for a long-term lease [7]. Group 2: Legal Allegations - The complaint alleges that Fermi and its executives violated federal securities laws by making false or misleading statements about tenant demand and the reliance on a single tenant's funding for Project Matador [6]. - Specific allegations include overstating tenant demand, failing to disclose risks related to the tenant's funding commitment, and misleading investors about the company's business prospects [6]. Group 3: Market Reaction - Following the announcement on December 12, 2025, that the First Tenant had terminated the Advance in Aid of Construction Agreement, Fermi's stock price dropped over 33%, closing at $10.09 per share, significantly below the IPO price [9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to allegations of violations of federal securities laws, particularly regarding misleading statements and guidance that led to significant investor losses [4][6]. Group 1: Allegations Against Agilon Health - The complaint alleges that agilon health and its executives made false and misleading statements, failing to disclose that they issued guidance for 2025 that was unrealistic given known industry challenges [6]. - It is claimed that the company materially overstated the financial benefits from strategic actions taken to mitigate risks, leading to misleading statements about its business and prospects [6]. - Following the release of disappointing second-quarter results on August 4, 2025, agilon health's stock plummeted by 51.5% the next day, reflecting the market's reaction to the disclosed information [7]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased agilon health securities between February 26, 2025, and August 4, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [1][4]. - There is a deadline of March 2, 2026, for investors to seek the role of lead plaintiff in the federal securities class action against agilon health [4]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [8].

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Agilon Health, Inc. for alleged misrepresentations regarding the company's guidance for 2025, affecting investors who purchased securities between February 26, 2025, and August 4, 2025 [1][2]. Group 1 - The lawsuit claims that the defendants made misrepresentations concerning the company's issued guidance for 2025 [2]. - Investors who wish to serve as lead plaintiffs must file papers by March 2, 2026, but participation in any recovery does not require serving as lead plaintiff [3]. - Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [4].

Core Viewpoint - A securities class action lawsuit has been filed against Bitdeer Technologies Group for failing to disclose critical information regarding its SEAL04 chip and its financial performance, leading to significant stock price decline [1][2]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York on behalf of individuals or entities that acquired Bitdeer securities between June 6, 2024, and November 10, 2025 [1]. - The complaint alleges that Bitdeer did not disclose that the SEAL04 chip, expected to have an energy efficiency of 5 J/TH, would be ready for use in A4 rigs with mass production anticipated to start in Q2 2025 [2]. Group 2: Financial Performance - On November 10, 2025, Bitdeer reported a net loss of $266.7 million, equating to $1.28 per share, primarily due to increased operating expenses related to research and development of its ASICs roadmap [2]. - Following the financial results announcement, Bitdeer's stock price fell from $17.65 per share to $15.02 per share, marking a decline of over 14% [2]. Group 3: Investor Information - Investors who purchased Bitdeer shares are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline on February 2, 2026 [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased F5, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The Class Period for the F5 securities is from October 28, 2024, to October 27, 2025, inclusive [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 17, 2026 [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3] Group 3: Case Allegations - The lawsuit alleges that F5's management misrepresented the company's revenue outlook and growth potential while downplaying risks associated with seasonality and macroeconomic factors [4] - It is claimed that F5 was experiencing a significant security incident that jeopardized both client security and the company's future prospects [4] - The lawsuit asserts that when the true information became public, investors suffered damages due to the misleading statements made by F5 [4]